Our findings indicate that the observed elevation in IRAK and TRAF6 expression in the FCA-induced RA model is associated with the notable increase in the expression of MYD88 and TLR4, supporting their association with the inflammatory processes observed in the RA model and further affirm the inflammatory effect of FCA treatment. The gene discussed is MYD88; the disease is rheumatoid arthritis.